Загрузка...
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
BACKGROUND: The introduction of immune checkpoint inhibitors has led to a survival benefit in patients with advanced melanoma; however data on the adoption of immunotherapy in the community are scarce. METHODS: Using the National Cancer Database, we identified 4725 patients aged ≥20 diagnosed with m...
Сохранить в:
| Опубликовано в: : | J Immunother Cancer |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6836520/ https://ncbi.nlm.nih.gov/pubmed/31699149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0782-y |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|